HHealthcare Read More 3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 DrugsNovember 10, 2025 Eli Lilly has been investing in radiopharmaceuticals, which can help revolutionize cancer care in the future. Its early…
MMedication Read More Dr. Oz made a stunning estimate after Trump’s obesity drug deals: ’135 billion’ pounds?!November 8, 2025 Dr. Mehmet Oz was front and center Thursday as President Donald Trump unveiled a new deal with two…
MMedication Read More Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharmaNovember 8, 2025 New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
HHealthcare Read More Fat loss drug top pharma seller, Augmentin no 2November 8, 2025 NEW DELHI: Weight-loss therapy drug Eli Lilly’s Mounjaro has become the top selling brand in the domestic pharma…
HHealthcare Read More Mark Cuban Praises TrumpRx Deal With Eli Lilly, Novo NordiskNovember 7, 2025 When President Trump told an audience in October that he hoped to cut the cost of Ozempic down…
HHealthcare Read More TrumpRx to offer discount weight loss drugs after Lilly, Novo dealsNovember 6, 2025 WASHINGTON — The Trump administration announced a deal Thursday to expand access to popular obesity drugs made by…
MMedication Read More Weight-Loss Drug Zepbound Gets Walmart D2C PricingNovember 5, 2025 Consumers will soon be able to pick up single-dose vials of the weight loss drug Zepbound at Walmart…
HHealthcare Read More Is Eli Lilly a Millionaire Maker?November 5, 2025 Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…
MMedication Read More Massive sales for weight loss drugs spur Eli Lilly’s Q3October 31, 2025 As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn…
MMedication Read More Eli Lilly says weight-loss pill a candidate for speedy approval under new US programOctober 31, 2025 By Mrinalika Roy and Patrick Wingrove (Reuters) -Eli Lilly said on Thursday its experimental weight-loss pill met most…
HHealthcare Read More Lilly invests in epigenetic reprogramming biotechOctober 22, 2025 NewLimit adds $45m in new funding at a $1.6bn valuation following preclinical progress that brings clinical trials closer…
MMedication Read More Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechangerOctober 18, 2025 Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…